UCB's Neupro allowed to be fully available in the EU market
This article was originally published in Scrip
Executive Summary
A new cold-store storage and distribution system for UCB's Neupro (rotigotine) transdermal patches has been cleared by the European Medicine Agency's advisory committee, the CHMP, allowing the product to be fully available again, once the positive opinion is approved by the European Commission.